Emergent BioSolutions Inc (EBS)
1.97
-0.21
(-9.63%)
USD |
NYSE |
Apr 25, 16:00
1.97
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions 1 Year Total Returns (Daily): -78.50% for April 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 24, 2024 | -78.50% |
April 23, 2024 | -77.92% |
April 22, 2024 | -79.17% |
April 19, 2024 | -80.93% |
April 18, 2024 | -83.00% |
April 17, 2024 | -83.77% |
April 16, 2024 | -83.54% |
April 15, 2024 | -83.29% |
April 12, 2024 | -83.37% |
April 11, 2024 | -83.42% |
April 10, 2024 | -81.99% |
April 09, 2024 | -78.12% |
April 08, 2024 | -78.03% |
April 05, 2024 | -77.70% |
April 04, 2024 | -77.02% |
April 03, 2024 | -76.92% |
April 02, 2024 | -79.15% |
April 01, 2024 | -77.80% |
March 28, 2024 | -71.57% |
March 27, 2024 | -70.77% |
March 26, 2024 | -69.88% |
March 25, 2024 | -68.64% |
March 22, 2024 | -69.06% |
March 21, 2024 | -69.77% |
March 20, 2024 | -68.90% |
Date | Value |
---|---|
March 19, 2024 | -69.70% |
March 18, 2024 | -69.58% |
March 15, 2024 | -74.61% |
March 14, 2024 | -75.77% |
March 13, 2024 | -76.50% |
March 12, 2024 | -75.95% |
March 11, 2024 | -71.10% |
March 08, 2024 | -74.01% |
March 07, 2024 | -74.16% |
March 06, 2024 | -70.31% |
March 05, 2024 | -70.75% |
March 04, 2024 | -72.81% |
March 01, 2024 | -71.89% |
February 29, 2024 | -73.91% |
February 28, 2024 | -74.15% |
February 27, 2024 | -76.43% |
February 26, 2024 | -79.21% |
February 23, 2024 | -80.84% |
February 22, 2024 | -79.97% |
February 21, 2024 | -80.52% |
February 20, 2024 | -90.67% |
February 16, 2024 | -89.45% |
February 15, 2024 | -88.61% |
February 14, 2024 | -87.25% |
February 13, 2024 | -87.91% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.67%
Minimum
Feb 20 2024
211.8%
Maximum
Aug 05 2020
-22.09%
Average
-46.15%
Median
1 Year Total Returns (Daily) Benchmarks
Avid Bioservices Inc | -64.81% |
Viking Therapeutics Inc | 205.1% |
FibroGen Inc | -94.17% |
Avinger Inc | -57.94% |
RAPT Therapeutics Inc | -57.87% |